Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, novembre 21
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
HCA Healthcare Inc
HCA
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$475.57
15.24
3.31%
À la clôture: Nov 20, 4:00 PM EST
$476.00
0.43
0.09%
Après les heures: 6:35 PM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Options
Rapport sur les stocks
HCA Healthcare Financials
HCA Healthcare (HCA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street
Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
Piero Cingari
HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results
HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.
Avi Kapoor
HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock
HCA Healthcare beat Q3 2026 estimates and raised guidance, but shares slid following a $400 million pretax hit from rising uninsured patient volumes.
Vandana Singh
PRO
HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est
HCA Healthcare (NYSE:HCA) raises FY2026 GAAP EPS guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 analyst estimate. Raises FY2026 sales outlook from $77.000 billion-$79.500 billion to $78.250 billion-$79.500
Benzinga Newsdesk
PRO
HCA Healthcare Q3 Adj. EPS $7.22 Beats $6.66 Estimate, Sales $19.849B Beat $19.332B Estimate
Benzinga Newsdesk
Visa, Coca-Cola On Deck Tuesday As Payments Growth, Global Demand Face Test
Visa is Tuesday’s most material report, with investors looking for continued payments growth after a strong run in the stock. Coca-Cola, HSBC Holdings, Novartis, Boeing and S&P Global report before the open; Seagate
Benzinga Insights